News


All News

Houston — Dermatologists need to urge patients with herpes infections to take a nucleoside analog drug daily to prevent the transmission of genital herpes, according to Stephen Tyring, M.D., Ph.D., M.B.A., professor of dermatology, University of Texas Health Sciences Center, Houston.

Geneva, Switzerland — A case study reported in the Archives of Internal Medicine highlights that a condition such as scurvy could occur in patients who are not thought to be at high risk for developing the condition.

Dr. Harper insists that oral hormones are a safe and effective treatment for women under the age of 35 who have no other risk factors.

The tongue is often the site for choristomas, a condition where normal tissue is in an abnormal place.

Results from in vitro and preclinical in vivo studies suggest that topically applied coenzyme Q10 (CoQ10) has exciting potential as a safe and effective anti-tumor agent for treating and preventing recurrence of skin cancer as well as other types of malignancies, say researchers from the department of dermatology and cutaneous surgery, University of Miami Leonard M. Miller School of Medicine.

National report — The suicide of Maryland-based phlebologist Scott N. LaBaer, M.D., this spring serves as a reminder that on average, doctors commit suicide more frequently than does the general population

Newtown, Pa. — CollaGenex Pharmaceuticals announces the "highly significant" positive outcomes of two phase 3, double-blinded, placebo-controlled clinical trials designed to evaluate the safety and efficacy of Oracea for the treatment of rosacea.

Exton, Pa. — Isolagen, which specializes in the development and commercialization of autologous cellular therapies for tissue regeneration, has designed an automated cellular expansion system (ACE) to propagate and harvest cells more efficiently and cost-effectively than other cell harvesting systems currently available.

National report -- A recent survey of dermatologists and managed care decision-makers could serve as a wake-up call regarding the relationship between the specialty and managed care, say physicians contacted by Dermatology Times.

National report — An apparent decline in the total numbers of U.S. principal investigators (PIs) and clinical trials could impact drug availability and, ultimately, the pharmaceutical industry's ability to innovate, according to a recent study.

It's not unusual today for plastic surgeons and dermatologists to share a practice, nor is it uncommon for husbands and wives to practice together, but 30 years ago when Saida and Sherwood Baxt began their dermatology/plastic surgery practice they were a rare breed — virtually unique, in fact. Still, it was a move they found to be a wonderful experience for them and beneficial for their patients. It doesn't hurt when the team is a mutual admiration society, either.

Cosmetic surgery practices know that starting on time is critical to managing a high volume of patients, but many practices are discovering the rewards of opening earlier in the day. A 6:30 a.m. starting time may seem ridiculous at first glance, but it can bring many benefits to patients, staff and your bottom line.

Vienna, Austria — Until recently, physicians had few nonsurgical options for treating nonmelanoma skin cancer. That could be changing, however, as researchers learn more about photodynamic therapy (PDT) and newer pharmaceuticals, as well as new uses for older drugs.

Boston University researchers are among those looking into the reciprocal relationship between aging and cancer, and how to tweak nature's response so that people can get the cancer prevention benefits without encouraging skin aging.

Vienna, Austria — A recent study suggests that the development of melanoma results in expression of retroviral genes and production of retroviral particles, neither of which are found in normal melanocytes or other tissues.

New Orleans — Mycosis fungoides (MF), the most common form of cutaneous T-cell lymphoma, has been most commonly treated in its early stages with skin-directed therapies such as topical corticosteroids, nitrogen mustard, UVB, PUVA and total skin electron beam irradiation. More recently, dermatologists have begun using narrow-band UVB with a spectrum peak of 311 nm as an alternative treatment for early-stage MF.

Antipityrosporal 1 percent ciclopirox shampoo can be used weekly or once every two weeks to treat seborrheic dermatitis and prophylactically to prevent its recurrence, according to a study published in the Archives of Dermatology in January.

San Diego — The lipid enhanced, emollient cream formulation of hydrocortisone butyrate 0.1 percent (Locoid, Ferndale) effectively treats moderate to severe atopic dermatitis (AD) in children and does so with excellent systemic safety, at least when used over a period of up to four weeks, said Lawrence F. Eichenfield, M.D., at the Pediatric Dermatology for the Practitioner Meeting here.

New Orleans — Xerostomia can complicate the diagnosis and management of various oral diseases and is an important condition to recognize and treat, said Susan L. Zunt, D.D.S., M.S., at the 63rd Annual Meeting of the American Academy of Dermatology, here.

Orlando — Complications as serious as death are occurring because of improper use of lasers, light sources and radiofrequency devices, according to a study presented here at the American Society for Laser Medicine and Surgery meeting.

Orlando — A device to treat pseudofolliculitis barbae will permit users to avoid developing the condition as well as reduce their frequency of shaving, according to a small study presented here at the meeting of the American Society for Laser Medicine and Surgery.